Crisaborole Impurity 45, identified by its CAS number 1785498-37-4, is a chemical compound that is recognized as an impurity associated with crisaborole, a topical medication used primarily for the treatment of atopic dermatitis. While specific details about its physical and chemical properties may not be widely documented, impurities like this one are typically characterized by their molecular structure, stability, and potential effects on the efficacy and safety of the primary compound. In general, impurities can arise during the synthesis of pharmaceuticals and may influence the overall quality of the drug product. The characterization of such impurities often involves techniques like chromatography and mass spectrometry to determine their identity and concentration. Understanding the properties of impurities is crucial for regulatory compliance and ensuring the safety of pharmaceutical formulations. As with any chemical substance, handling should be conducted with appropriate safety measures, and its use should be guided by relevant regulatory standards.

Crisaborole Impurity 45

1785498-37-4: Crisaborole Impurity 45, identified by its CAS number 1785498-37-4, is a chemical compound that is recognized as an impurity associated with crisaborole, a topical medication used primarily for the treatment of atopic dermatitis. While specific details about its physical and chemical properties may not be widely documented, impurities like this one are typically characterized by their molecular structure, stability, and potential effects on the efficacy and safety of the primary compound. In general, impurities can arise during the synthesis of pharmaceuticals and may influence the overall quality of the drug product. The characterization of such impurities often involves techniques like chromatography and mass spectrometry to determine their identity and concentration. Understanding the properties of impurities is crucial for regulatory compliance and ensuring the safety of pharmaceutical formulations. As with any chemical substance, handling should be conducted with appropriate safety measures, and its use should be guided by relevant regulatory standards.

CAS 1785498-37-4

Crisaborole Impurity 45

Crisaborole Impurity 18

Ref: 4Z-C-278024